ABT
Price
$115.74
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
69 days until earnings call
TFX
Price
$193.98
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
98 days until earnings call
Ad is loading...

ABT vs TFX

Header iconABT vs TFX Comparison
Open Charts ABT vs TFXBanner chart's image
Abbott Laboratories
Price$115.74
Change-$0.00 (-0.00%)
Volume$4.76M
CapitalizationN/A
Teleflex
Price$193.98
Change-$0.00 (-0.00%)
Volume$365.08K
CapitalizationN/A
ABT vs TFX Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABT vs. TFX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongSell and TFX is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ABT: $115.74 vs. TFX: $193.98)
Brand notoriety: ABT: Notable vs. TFX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 92% vs. TFX: 97%
Market capitalization -- ABT: $194.5B vs. TFX: $10.49B
ABT [@Medical Specialties] is valued at $194.5B. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 1 FA rating(s) are green whileTFX’s FA Score has 2 green FA rating(s).

  • ABT’s FA Score: 1 green, 4 red.
  • TFX’s FA Score: 2 green, 3 red.
According to our system of comparison, ABT is a better buy in the long-term than TFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 4 TA indicator(s) are bullish while TFX’s TA Score has 4 bullish TA indicator(s).

  • ABT’s TA Score: 4 bullish, 5 bearish.
  • TFX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ABT is a better buy in the short-term than TFX.

Price Growth

ABT (@Medical Specialties) experienced а -0.91% price change this week, while TFX (@Medical Specialties) price change was -3.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.23%. For the same industry, the average monthly price growth was +0.54%, and the average quarterly price growth was -4.87%.

Reported Earning Dates

ABT is expected to report earnings on Jan 22, 2025.

TFX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-2.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than TFX($10.5B). ABT has higher P/E ratio than TFX: ABT (34.38) vs TFX (29.48). ABT YTD gains are higher at: 7.250 vs. TFX (-21.843). ABT has higher annual earnings (EBITDA): 10.5B vs. TFX (761M). ABT has more cash in the bank: 7.28B vs. TFX (223M). TFX has less debt than ABT: TFX (1.93B) vs ABT (15.6B). ABT has higher revenues than TFX: ABT (40.1B) vs TFX (2.97B).
ABTTFXABT / TFX
Capitalization194B10.5B1,848%
EBITDA10.5B761M1,380%
Gain YTD7.250-21.843-33%
P/E Ratio34.3829.48117%
Revenue40.1B2.97B1,348%
Total Cash7.28B223M3,264%
Total Debt15.6B1.93B810%
FUNDAMENTALS RATINGS
ABT vs TFX: Fundamental Ratings
ABT
TFX
OUTLOOK RATING
1..100
6152
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
5781
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
6121
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (10) in the Medical Specialties industry is in the same range as TFX (18). This means that ABT’s stock grew similarly to TFX’s over the last 12 months.

ABT's Profit vs Risk Rating (36) in the Medical Specialties industry is somewhat better than the same rating for TFX (100). This means that ABT’s stock grew somewhat faster than TFX’s over the last 12 months.

ABT's SMR Rating (57) in the Medical Specialties industry is in the same range as TFX (81). This means that ABT’s stock grew similarly to TFX’s over the last 12 months.

ABT's Price Growth Rating (34) in the Medical Specialties industry is in the same range as TFX (64). This means that ABT’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (21) in the Medical Specialties industry is somewhat better than the same rating for ABT (61). This means that TFX’s stock grew somewhat faster than ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTTFX
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 23 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG41.922.24
+5.65%
Bright Minds Biosciences
ABG264.796.13
+2.37%
Asbury Automotive Group
KDP33.570.23
+0.69%
Keurig Dr Pepper
STEL29.76-0.37
-1.23%
Stellar Bancorp
RVP0.69-0.03
-4.01%
Retractable Technologies

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-0.60%
MDT - ABT
46%
Loosely correlated
-0.37%
SYK - ABT
43%
Loosely correlated
+0.32%
TMO - ABT
41%
Loosely correlated
+0.21%
SNN - ABT
40%
Loosely correlated
+0.16%
TFX - ABT
39%
Loosely correlated
-0.82%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with SNN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then SNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-0.82%
SNN - TFX
59%
Loosely correlated
+0.16%
MDT - TFX
49%
Loosely correlated
-0.37%
IDXX - TFX
46%
Loosely correlated
+0.90%
WAT - TFX
44%
Loosely correlated
-0.04%
ICUI - TFX
41%
Loosely correlated
-1.80%
More